1. Home
  2. PSIX vs NUVB Comparison

PSIX vs NUVB Comparison

Compare PSIX & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PSIX

Power Solutions International Inc.

HOLD

Current Price

$66.17

Market Cap

1.7B

Sector

Industrials

ML Signal

HOLD

NUVB

Nuvation Bio Inc.

HOLD

Current Price

$4.52

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSIX
NUVB
Founded
1985
2018
Country
United States
United States
Employees
N/A
291
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PSIX
NUVB
Price
$66.17
$4.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
$99.95
$11.38
AVG Volume (30 Days)
749.2K
4.5M
Earning Date
05-07-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$23.44
$190.15
Revenue Next Year
$16.18
$62.54
P/E Ratio
$17.20
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.10
$1.57
52 Week High
$121.47
$9.75

Technical Indicators

Market Signals
Indicator
PSIX
NUVB
Relative Strength Index (RSI) 53.50 45.66
Support Level $63.84 $4.07
Resistance Level $69.30 $5.55
Average True Range (ATR) 5.14 0.22
MACD 1.60 0.06
Stochastic Oscillator 89.87 77.78

Price Performance

Historical Comparison
PSIX
NUVB

About PSIX Power Solutions International Inc.

Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States.

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in different stages of development. The Company generates revenue from out-licensing collaborative agreements, including product revenue, upfront license fees, royalty revenue, and research and development services revenue. The Company generates the majority of its revenue from Japan.

Share on Social Networks: